Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Development of the 'REadiness SElf-assessment (RESEA) guide' to assist low and middle-income countries with establishing safe and sustainable radiotherapy services: a pragmatic sequential mixed qualitative methods project.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Background: Improving access to radiotherapy services in low and middle-income countries (LMICs) is challenging. Many LMICs' radiotherapy initiatives fail because of multi-faceted barriers leading to significant wastage of scarce resources. Supporting LMICs to self-assess their readiness for establishing radiotherapy services will help to improve cancer outcomes by ensuring safe, effective and sustainable evidenced-based cancer care. The aim of the study was to develop practical guidance for LMICs on self-assessing their readiness to establish safe and sustainable radiotherapy services.
      Methods: The Access to Radiotherapy for Cancer treatment (ARC) Project was a pragmatic sequential mixed qualitative methods design underpinned by the World Health Organisation's 'Innovative Care for Chronic Conditions Framework' and 'Health System Building Blocks Framework for Action' conceptual frameworks. This paper reports on the process of overall data integration and meta-inference from previously published components comprising a systematic review and two-part qualitative study (semi-structured interviews and a participant validation process). The meta-inferences enabled a series of radiotherapy readiness self-assessment requirements to be generated, formalised as a REadiness SElf-Assessment (RESEA) Guide' for use by LMICs.
      Findings: The meta-inferences identified a large number of factors that acted as facilitators and/or barriers, depending on the situation, which include: awareness and advocacy; political leadership; epidemiological data; financial resources; basic physical infrastructure; radiation safety legislative and regulatory framework; project management; and radiotherapy workforce training and education. 'Commitment', 'cooperation', 'capacity' and 'catalyst' were identified as the key domains enabling development of radiotherapy services. Across these four domains, the RESEA Guide included 37 requirements and 120 readiness questions that LMICs need to consider and answer as part of establishing a new radiotherapy service.
      Conclusions: The RESEA Guide provides a new resource for LMICs to self-assess their capacity to establish safe and sustainable radiotherapy services. Future evaluation of the acceptability and feasibility of the RESEA Guide is needed to inform its validity. Further work, including field study, is needed to inform further refinements. Exploratory and confirmatory factor analyses are required to reduce the data set and test the fit of the four-factor structure (commitment, cooperation, capacity and catalyst) found in the current study.
    • References:
      J Eval Clin Pract. 2016 Feb;22(1):112-121. (PMID: 24814988)
      Ann Glob Health. 2015 Nov-Dec;81(6):851-62. (PMID: 27108152)
      Int J Public Health. 2018 Dec;63(9):1047-1057. (PMID: 29974131)
      Implement Sci. 2009 Oct 19;4:67. (PMID: 19840381)
      J Infect Dis. 2014 Nov 1;210 Suppl 1:S504-13. (PMID: 24690667)
      Lancet Oncol. 2015 Sep;16(10):1153-86. (PMID: 26419354)
      Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):687-9. (PMID: 25752377)
      Clin Oncol (R Coll Radiol). 2017 Feb;29(2):84-92. (PMID: 27939337)
      Ecancermedicalscience. 2019 Jul 25;13:942. (PMID: 31552115)
      Clin Oncol (R Coll Radiol). 2015 Feb;27(2):107-14. (PMID: 25455407)
      Health Inf Manag. 2017 Jan;46(1):32-41. (PMID: 27486183)
      BMC Med Inform Decis Mak. 2016 Feb 24;16:24. (PMID: 26907792)
      Qual Health Res. 2009 Nov;19(11):1523-4. (PMID: 19843962)
      Asia Pac J Clin Oncol. 2020 Apr;16(2):e74-e85. (PMID: 32030881)
      Clin Oncol (R Coll Radiol). 2017 Feb;29(2):72-83. (PMID: 27916340)
      Phys Med. 2014 Nov;30(7):791-8. (PMID: 25096162)
      Clin Oncol (R Coll Radiol). 2017 Feb;29(2):99-104. (PMID: 28040092)
      Lancet Oncol. 2006 Jul;7(7):584-95. (PMID: 16814210)
      Lancet Oncol. 2017 Oct;18(10):e587-e594. (PMID: 28971825)
      Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56. (PMID: 24279835)
      Phys Med. 2020 Mar;71:88-99. (PMID: 32109751)
    • Contributed Indexing:
      Keywords: Assessment; Establishment; Low and middle-income countries; Radiotherapy; Readiness; Sustainable
    • Publication Date:
      Date Created: 20210324 Date Completed: 20210514 Latest Revision: 20210514
    • Publication Date:
      20240105
    • Accession Number:
      PMC7988910
    • Accession Number:
      10.1186/s12913-021-06274-x
    • Accession Number:
      33757517